[ABCL] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -104.02%
YoY- -192.08%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 12,192 21,545 101,383 45,917 316,581 139,331 5,508 69.92%
PBT -48,148 -31,412 46,587 -6,886 230,809 84,710 -24,972 54.97%
Tax -8,038 -1,519 19,963 -101 62,236 24,762 -3,592 71.16%
NP -40,110 -29,893 26,624 -6,785 168,573 59,948 -21,380 52.17%
Tax Rate - - -42.85% - -26.96% -29.23% - -
Total Cost 52,302 51,438 74,759 52,702 148,008 79,383 26,888 55.88%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -328.99 -138.75 26.26 -14.78 53.25 43.03 -388.16 -10.44%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.14 -0.10 0.08 -0.02 0.54 0.21 -0.08 45.26%
EPS Diluted -0.14 -0.10 0.08 -0.02 0.54 0.21 -0.08 45.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.